Provided by Tiger Fintech (Singapore) Pte. Ltd.

INTELLIGENT BIO SOLUTIONS INC

1.36
+0.01000.74%
Post-market: 1.400.0394+2.90%18:06 EDT
Volume:38.15K
Turnover:52.13K
Market Cap:9.22M
PE:-0.43
High:1.42
Open:1.36
Low:1.33
Close:1.35
Loading ...

Intelligent Bio Solutions Achieves 94.1% Accuracy in Method Comparison Study, Following Positive Pk Study Results

THOMSON REUTERS
·
26 Nov 2024

Intelligent Bio Solutions: Fingerprinting Drug Screening System on Path to FDA 510(K) Submission, Expected in Fourth Calendar Quarter of 2024

THOMSON REUTERS
·
26 Nov 2024

Intelligent Bio Solutions to Participate in the Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference

GlobeNewswire
·
21 Nov 2024

INBS Stock Declines Despite Positive Results of Pharmacokinetic Study

Zacks
·
18 Nov 2024

Intelligent Bio Solutions First Quarter 2025 Earnings: US$0.70 loss per share (vs US$12.49 loss in 1Q 2024)

Simply Wall St.
·
14 Nov 2024

BRIEF-Intelligent Bio Solutions Announces Positive Results Of PK Study, A Key Milestone On Path To FDA 510(K) Submission

Reuters
·
13 Nov 2024

Intelligent Bio Solutions Inc - FDA 510(K) Clearance Could Introduce Inbs Technology to US in 2025

THOMSON REUTERS
·
13 Nov 2024

Intelligent Bio Solutions Announces Positive Results of Pk Study, a Key Milestone on Path to FDA 510(K) Submission

THOMSON REUTERS
·
13 Nov 2024

Intelligent Bio Solutions First Quarter 2025 Earnings: US$0.70 loss per share (vs US$12.49 loss in 1Q 2024)

Simply Wall St.
·
10 Nov 2024

Intelligent Bio Solutions Q1 EPS $(0.70) Misses $(0.53) Estimate, Sales $872.29K Miss $1.75M Estimate

Benzinga
·
07 Nov 2024

Intelligent Bio Solutions Q1 Basic EPS USD -0.7

THOMSON REUTERS
·
07 Nov 2024

Press Release: Intelligent Bio Solutions Reports Fiscal 2025 First Quarter Financial Results and Operational Highlights

Dow Jones
·
07 Nov 2024